Off-Label Use of Second Generation Antipsychotics in Psychiatric Inpatients - Data from the AMSP Study Group

被引：0
作者：
Konstantinidis, A. [1 ]
Kutzelnigg, A. [1 ]
Moser, U. [1 ]
Grohmann, R. [2 ]
Jaquenoud Sirot, E. [3 ]
Engel, R. [2 ]
Kasper, S. [1 ]
机构：
[1] Med Univ Vienna, Dept Psychiat & Psychotherapy, Div Biol Psychiat, Vienna, Austria
[2] Univ Munich, Dept Psychiat, D-8000 Munich, Germany
[3] Psychiat Dienste AargauAG, Brugg, Switzerland
来源：
DRUG SAFETY | 2008年 / 31卷 / 10期
关键词：
Clozapine; Risperidone; Olanzapine; Quetiapine; Aripiprazole;
D O I：
10.2165/00002018-200831100-00107
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
105
引用
收藏
页码：926 / 926
页数：1
相关论文
共 30 条
  • [21] Off-label Use of Memantine as Adjunctive Treatment in Schizophrenia: A Retrospective Case Series Study
    John, J. P.
    Lukose, A.
    Manjunath, S.
    PHARMACOPSYCHIATRY, 2014, 47 (06) : 202 - 209
  • [22] Clozapine-associated adverse drug reactions in 38,349 psychiatric inpatients: drug surveillance data from the AMSP project between 1993 and 2016
    Bleich, Lene
    Grohmann, Renate
    Greil, Waldemar
    Dabbert, Dominik
    Erfurth, Andreas
    Toto, Sermin
    Seifert, Johanna
    JOURNAL OF NEURAL TRANSMISSION, 2024, 131 (09) : 1117 - 1134
  • [23] Effect of Clozapine vs Other Second-Generation Antipsychotics on Hospitalization and Seclusion: A Retrospective Mirror-Image Study in a Japanese Public Psychiatric Hospital
    Misawa, Fuminari
    Suzuki, Takefumi
    Fujii, Yasuo
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2017, 37 (06) : 664 - 668
  • [24] Randomized open-label study of second-generation antipsychotics for the treatment of schizophrenia: 104-week final results of the JUMPs study assessing treatment discontinuation, remission, and social functioning
    Ishigooka, Jun
    Nakagome, Kazuyuki
    Ohmori, Tetsuro
    Iwata, Nakao
    Inada, Ken
    Iga, Jun-ichi
    Kishi, Taro
    Fujita, Kiyoshi
    Kikuchi, Yuka
    Shichijo, Toshiaki
    Tabuse, Hideaki
    Koretsune, Shotatsu
    Terada, Hiroshi
    Terada, Haruko
    Kishimoto, Toshifumi
    Tsutsumi, Yuichiro
    Ohi, Kazutaka
    BMC PSYCHIATRY, 2024, 24 (01)
  • [25] Differences in Body Mass Index z-Scores and Weight Status in a Dutch Pediatric Psychiatric Population With and Without Use of Second-Generation Antipsychotics
    de Hoogd, Sjoerd
    Overbeek, Wieske A.
    Heerdink, Eibert R.
    Correll, Christoph U.
    de Graeff, Elisabeth R.
    Staal, Wouter G.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2012, 22 (02) : 166 - 173
  • [26] Effects of Six Second Generation Antipsychotics on Body Weight and Metabolism - Risk Assessment and Results from a Prospective Study
    Tschoner, A.
    Engl, J.
    Rettenbacher, M.
    Edlinger, M.
    Kaser, S.
    Tatarczyk, T.
    Effenberger, M.
    Patsch, J. R.
    Fleischhacker, W. W.
    Ebenbichler, C. F.
    PHARMACOPSYCHIATRY, 2009, 42 (01) : 29 - 34
  • [27] Discontinuation and remission rates and social functioning in patients with schizophrenia receiving second-generation antipsychotics: 52-week evaluation of JUMPs, a randomized, open-label study
    Ishigooka, Jun
    Nakagome, Kazuyuki
    Ohmori, Tetsuro
    Iwata, Nakao
    Inada, Ken
    Iga, Jun-ichi
    Kishi, Taro
    Fujita, Kiyoshi
    Kikuchi, Yuka
    Shichijo, Toshiaki
    Tabuse, Hideaki
    Koretsune, Shotatsu
    Terada, Hiroshi
    Terada, Haruko
    Kishimoto, Toshifumi
    Tsutsumi, Yuichiro
    Kanda, Yoshiki
    Ohi, Kazutaka
    Sekiyama, Kanji
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2022, 76 (01) : 22 - 31
  • [28] Low-Dose of Bergamot-Derived Polyphenolic Fraction (BPF) Did Not Improve Metabolic Parameters in Second Generation Antipsychotics- Treated Patients: Results from a 60-days Open-Label Study
    Bruno, Antonio
    Pandolfo, Gianluca
    Crucitti, Manuela
    Cacciola, Massimo
    Santoro, Vincenza
    Spina, Edoardo
    Zoccali, Rocco A.
    Muscatello, Maria R. A.
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [29] The effect on relapse rate and psychiatric symptomatology: Switching a combination of first- and second-generation antipsychotic polypharmacy to antipsychotic monotherapy in long-term inpatients with schizophrenia and related disorders. A pragmatic randomized open-label trial (SwAP trial)
    Shakir, Mushde
    Willems, Anne E.
    van Harten, Peter N.
    van Lutterveld, Remko
    Tenback, Diederik E.
    SCHIZOPHRENIA RESEARCH, 2022, 243 : 187 - 194
  • [30] Cardiovascular and cerebrovascular risk factors and events associated with second-generation antipsychotic compared to antidepressant use in a non-elderly adult sample: results from a claims-based inception cohort study
    Correll, Christoph U.
    Joffe, Benjamin I.
    Rosen, Lisa M.
    Sullivan, Timothy B.
    Joffe, Russell T.
    WORLD PSYCHIATRY, 2015, 14 (01) : 56 - 63
123